dpp-4 inhibitors and glp-1 agonists GLP-1RAs: cardiovascular safety and benefits DPP4 Inhibitors vs GLP-1 Agonists

36 Moreover, GLP-1 RAs improve lipid profiles by decreasing serum cholesterol and triglyceride levels and increasing high-density lipoprotein (HDL) levels contributing to cardiovascular protection

We are highlighting amylin as the hottest new mechanism for obesity, Leerink Partners analysts wrote in a Tuesday note to investors, explaining that amylin mostly works as a satiety signal and affects hedonic aspects of eating. The molecule acts on several regions of the brain to lower the feeling of being rewarded after eating

Nausea, vomiting, and diarrhea are common, and depending on the person there are real risks of acute kidney injury, gallstones, and pancreatitis, plus muscle and bone loss in older adults

Eur J Endocrinol 181(6):R211R234 Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V et al (2021) A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis

Skipping meals or eating mostly refined carbs can make swings worse

We shouldnt just throw up our hands and say theres nothing we can do. Most Popular The Air Quality Index and how to use it, explained The mysterious symptom popping up in some GLP-1 users Trumps election fraud speech was a weirdly good sign for American democracy Take a mental break with the newest Vox crossword Francesca Hong might be the first-ever socialist governor